Protein kinase C (PKC) potentiates NMDA receptors in hippocampal, trigeminal, and spinal neurons. Although PKC phosphorylates the NMDA receptor subunit NR1 at four residues within the C terminal splice cassette C1, the molecular mech- influx. Contrary to expectation, splicing out the two Cterminal splice cassettes of NR1 enhanced PKC potentiation in a manner independent of extracellular Ca 2ϩ . This observation indicates that PKC potentiation does not require phosphorylation of the C1 cassette of the NR1 subunit. PKC potentiation of NMDA receptors in vivo is likely to be affected by Ca 2ϩ amplification of the potentiated signal; the degree of amplification will depend in part on alternative splicing of the NR1 subunit, which is regulated developmentally and in a cell-specific manner.
Protein kinase C (PKC) potentiates NMDA receptors in hippocampal, trigeminal, and spinal neurons. Although PKC phosphorylates the NMDA receptor subunit NR1 at four residues within the C terminal splice cassette C1, the molecular mechanisms underlying PKC potentiation of NMDA responses are not yet known. The present study examined the role of Ca 2ϩ in PKC potentiation of recombinant NMDA receptors expressed in Xenopus oocytes. We found that Ca 2ϩ influx through PKCpotentiated NMDA receptors can further increase the NMDA response ("Ca 2ϩ amplification"). Ca 2ϩ amplification required a rise in intracellular Ca 2ϩ concentration at or near the intracellular end of the channel and was independent of Ca 2ϩ -activated Cl Ϫ current. Ca 2ϩ amplification depended on extracellular Ca 2ϩ concentration during NMDA application and not during PKC activation. Ca 2ϩ amplification was reduced by the membrane-permeant Ca 2ϩ -chelating agent BAPTA-AM. Mutant receptors with greatly reduced Ca 2ϩ permeability did not exhibit Ca 2ϩ amplification. Receptors containing the NR1 Nterminal splice cassette showed more Ca 2ϩ amplification, possibly because of their larger basal current and therefore greater Ca 2ϩ influx. Contrary to expectation, splicing out the two Cterminal splice cassettes of NR1 enhanced PKC potentiation in a manner independent of extracellular Ca 2ϩ . This observation indicates that PKC potentiation does not require phosphorylation of the C1 cassette of the NR1 subunit. PKC potentiation of NMDA receptors in vivo is likely to be affected by Ca 2ϩ amplification of the potentiated signal; the degree of amplification will depend in part on alternative splicing of the NR1 subunit, which is regulated developmentally and in a cell-specific manner.
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The NMDA class of glutamate receptors plays a critical role in synaptic plasticity, formation of neuronal circuitry, and excitotoxicity (for review, see Choi and Rothman, 1990; ConstantinePaton, 1990; Bliss and Collingridge, 1993) . Protein phosphorylation and dephosphorylation are thought to be important mechanisms of regulation of synaptic activity. The PKCactivating phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) enhances whole-cell currents (Gerber et al., 1989; Aniksztejn et al., 1992; Chen and Huang, 1992) and channel open probability (Chen and Huang, 1992) of NMDA receptors in hippocampal, trigeminal, and spinal neurons. TPA also potentiates NMDA responses in Xenopus oocytes expressing rat brain mRNA (Durand et al., 1992; Kelso et al., 1992; Urushihara et al., 1992) and recombinant NMDA receptors (Durand et al., 1992 (Durand et al., , 1993 Kutsuwada et al., 1992; Yamazaki et al., 1992; Mori et al., 1993) . Agonists of opioid receptors (Chen and Huang, 1991) , phosphoinositol-coupled metabotropic glutamate receptors (Aniksztejn et al., 1991 (Aniksztejn et al., , 1992 Kelso et al., 1992; Shen et al., 1995) , and muscarinic acetylcholine receptors (Markram and Segal, 1990 ) potentiate neuronal and recombinant NMDA receptors via activation of PKC. PKC phosphorylates specific residues in the C1 splice cassette in the cytoplasmic C terminus of the NMDA receptor subunit NR1 (Tingley et al., 1993) . Phosphorylation at these sites may regulate receptor interactions with the cytoskeleton and clustering at the membrane (Ehlers et al., 1995) but may decrease PKC potentiation (Durand et al., 1993; Sigel et al., 1994) . Ca 2ϩ modulates NMDA receptor activity by several mechanisms. Ca 2ϩ reduces single-channel conductance by binding in the ion channel (Jahr and Stevens, 1993) . Ca 2ϩ influx reduces open probability without change in single-channel conductance (producing "slow inactivation") (Legendre et al., 1993; Rosenmund et al., 1995) . Binding of Ca 2ϩ -calmodulin to the cytoplasmic C terminus decreases open probability and may contribute to Ca 2ϩ -dependent inactivation (Ehlers et al., 1996) . High extracellular Ca 2ϩ was reported to increase responses of recombinant NMDA receptors expressed in Xenopus oocytes (Koltchine et al., 1996) .
NMDA receptors are assembled from NR1 and NR2 subunits (for review, see Nakanishi, 1992; Westbrook, 1994; Mori and Mishina, 1995) . The NR1 subunit is encoded by a single gene, and alternative RNA splicing gives rise to eight possible splice variants (Sugihara et al., 1992) . NR2 subunits are of four types, NR2A-D, encoded by four different genes Monyer et al., 1992) . NMDA receptors are likely to be NR1/NR2 heteromeric complexes in the nervous system (Sheng et al., 1994; Behe et al., 1995; Blahos and Wenthold, 1996) . Although injection of NR1 subunit mRNA into oocytes leads to formation of functional receptors with different properties dependent on the splice variant (Durand et al., 1993; Zhang et al., 1994; Zukin and Bennett, 1995) , oocytes may provide an NR2 subunit. Oocytes provide a necessary subunit for two other heteromeric channels (Buller and White, 1990; Hedin et al., 1996) .
In the present study, we analyzed the effect of extracellular 
MATERIALS AND METHODS
Site-directed mutagenesis. Site-directed mutations were made with the oligonucleotide-directed in vitro mutagenesis system, version 2 (Amersham, Arlington Heights, IL) as described (Z heng et al., 1994) . In brief, NR1 011 and N R1 100 (nomenclature of N R1 splice variants according to Durand et al., 1993) were subcloned into the pBluescript SK(Ϫ) vector and used to transform the Escherichia coli strain DH5␣FЈIQ (Life Technologies, Gaithersburg, MD). Single-stranded DNA template was rescued with M13K07 helper phage (Bio-Rad, Hercules, CA). To make the channel mutants N R1 011 (N598R) and N R1 100 (N619R), we engineered a single codon substitution into the cloned N R1 011 and N R1 100 cDNAs to generate subunits carrying an arginine in place of asparagine in the second membrane domain M2. The following oligonucleotide was used for introduction of this change into the coding sequence 5Ј-CC TTCCCCAATGCCGGAGCGGAGCAGGACGCC -3Ј. To engineer the channel mutant N R1 111 (N619R), a BsmI-BamHI fragment containing exons 21 and 22 was shuttled from wild-type N R1 111 into the mutant NR1 100 (N619R) cDNA.
To introduce N1 insert mutations with reduced positive charges in the NR1 111 receptor, a BsmI-BamHI fragment containing exons 21 and 22 was shuttled from wild-type N R1 111 into the mutant M1, M2, and M3 (N R1 100 ) cDNAs (Z heng et al., 1994) . Mutant N R1 111 receptors were as follows: N1-1 (K192A, K193A, and R194A), N1-2 (R207A, R208A, and K211A), and N1-3 (K192A, K193A, R194A, R207A, R208A, and K211A). Codon substitutions were confirmed by DNA sequencing across mutationally altered and ligation regions with Sequenase version 2.1 (United States Biochemical, C leveland, OH).
R NA synthesis. NR1 011 cDNA was a gift from Dr. S. Nakanishi (Kyoto University, Kyoto, Japan); N R1 111 cDNA was a gift from Dr. V. R. Anantharam (University of Massachusetts, Worcester, M A) and subcloned to pBluescript SK(Ϫ) vector; N R1 100 cDNA was cloned in this laboratory (Durand et al., 1992) . Mutant N R1 receptors were generated as described above. N R2A was a gift from Dr. M. Mishina (Niigata University, Niigata, Japan). To generate templates for transcription, circular plasmid cDNAs were linearized with NotI (wild-type and mutant NR1 011 , N R2A) or BamHI (wild-type and mutant N R1 100 , NR1 111 ). Transcription reactions were performed with T7 and T3 polymerase (Ambion M EGAscript transcription kit, 4 hr at 37°C) in the presence of capped analog or a mMessage mMachine transcription kit (2 hr at 37°C).
Electrophysiolog ical e xperiments in Xenopus ooc ytes. Adult female Xenopus laevis (Xenopus I, Ann Arbor, M I) were anesthetized by immersion in ice water or 0.15% aminobenzoic acid ethyl ester, and oocytes were isolated and prepared as described (Kushner et al., 1988 (Kushner et al., , 1989 . Selected stage V and V I oocytes were injected with in vitro transcribed RNA (ϳ20 ng /cell; for heteromeric receptor expression, N R1 and N R2 were mixed in a ratio of 1:3) and maintained at 18°C in culture buffer (in mM: 103 NaC l, 2.5 KC l, 2 MgC l 2 , 2 CaCl 2 , and 5 H EPES, pH 7.5). Three to 7 d after injection, oocytes were clamped at Ϫ60 mV in Mg 2ϩ -free C a 2ϩ Ringer's solution (in mM: 116 NaC l, 2.0 KC l, 1.0 CaCl 2 , and 10 H EPES, pH 7.2), unless otherwise specified, with a two-electrode voltage-clamp amplifier (Dagan or Axon Instruments). NMDA (300 M) together with glycine (10 M) was bath-applied to elicit responses. Current amplitude was measured at the minimum immediately after the initial peak (indicated by arrows in sample records in Figs Ringer's solution immediately before each experiment. The extent of PKC potentiation varied from batch to batch of oocytes. Therefore, comparisons are within single batches of oocytes or between batches with the same degree of potentiation of a given receptor subtype. Data represent mean Ϯ SEM. Statistical analyses were performed by one-way ANOVA (GraphPad Prism version 3.0).
RESULTS

Extracellular Ca
2؉ affects PKC potentiation of recombinant NMDA receptors
To examine the effect of extracellular Ca 2ϩ on PKC potentiation of NMDA receptors, we used oocytes expressing recombinant NMDA receptors. We applied NMDA (300 M with 10 M glycine) to oocytes clamped at Ϫ60 mV in Ba 2ϩ or Ca 2ϩ Ringer's solution before and after application of TPA. We focused on three NR1 splice variants that differ in their potentiation by PKC: NR1 011 , which is prominent in forebrain and exhibits a relatively low level of potentiation by PKC; NR1 111 , which is also prominent in forebrain and exhibits a moderate level of PKC potentiation; and NR1 100 , which is prominent in midbrain and exhibits a high level of potentiation by PKC (Fig. 1 A) (Durand et al., 1993) . This choice of splice variants permitted us to evaluate the action of Ca 2ϩ on receptors with and without the N-terminal splice cassette N1 by comparison of NR1 011 and NR1 111 receptors and on receptors with and without the C -terminal splice cassettes C1 and C2 by comparison of NR1 100 and NR1 111 receptors. (When C2 is spliced out, a new unrelated reading frame is opened, which encodes an alternative cassette, C2Ј, of 22 amino acids before a new stop codon is reached.)
In 1 mM Ca 2ϩ Ringer's solution, TPA (100 nM) potentiated NMDA responses of NR1 011 -, NR1 111 -, and NR1 100 -injected oocytes to 3.1 Ϯ 0.2-fold (n ϭ 19), 6.2 Ϯ 0.4-fold (n ϭ 21), and 12.2 Ϯ 0.8-fold (n ϭ 16) of control NMDA responses, respectively ( Fig. 1 A,B) . In 1 mM Ba 2ϩ Ringer's solution, NMDA responses of all three splice variants lacked the initial peak current observed in the presence of extracellular Ca 2ϩ ( Fig. 1 A, bottom row) . In Ba 2ϩ , TPA potentiated NMDA responses of NR1 011 -, NR1 111 -, and NR1 100 -injected oocytes to 2.3 Ϯ 0.3-fold (n ϭ 8), 2.8 Ϯ 0.3-fold (n ϭ 8), and 5.7 Ϯ 0.4-fold (n ϭ 10) of the control responses, respectively ( Fig. 1 A, In Ba 2ϩ Ringer's solution, potentiation of NR1 011 receptors was virtually identical to that of NR1 111 receptors and about half of that of NR1 100 receptors ( Fig. 1 A,B) . Thus, PKC potentiation in Ba 2ϩ is little affected by the N1 cassette but is greater for the NR1 splice variants lacking the C-terminal splice cassettes C1 and C2 (see Durand et al., 1993) .
Native NMDA receptors are likely to be heteromeric receptors containing both NR1 and NR2 subunits (Sheng et al., 1994; Behe et al., 1995; Blahos and Wenthold, 1996) . To determine whether (1) alternative splicing of NR1 affects PKC potentiation of heteromeric receptors, and (2) there is Ca 2ϩ amplification of their responses, similar experiments were performed on oocytes expressing NR2A and one of the three NR1 subunits, NR1 011 , NR1 111 , and NR1 100 . In 1 mM Ca 2ϩ Ringer's solution, TPA potentiated NMDA responses of heteromeric NR1 011 /NR2A, NR1 111 /NR2A, and NR1 100 /NR2A receptors to 3.6 Ϯ 0.5-fold (n ϭ 4), 8.2 Ϯ 0.3-fold (n ϭ 4), and 13.7 Ϯ 1.8-fold (n ϭ 4) of control NMDA responses, respectively (Fig. 1C, open bars) . In Ba 2ϩ Ringer's solution, TPA potentiated NMDA responses of NR1 011 /NR2A, NR1 111 /NR2A, and NR1 100 /NR2A receptors to 3.6 Ϯ 0.4-fold (n ϭ 4), 4.7 Ϯ 0.6-fold (n ϭ 5), and 7.0 Ϯ 0.7-fold (n ϭ 5) of the control responses, respectively (Fig. 1C , filled bars). These findings indicate that PKC potentiation of heteromeric NR1/NR2A receptors is affected by alternative splicing and exhibits Ca 2ϩ amplification of the potentiated responses. The dependence of PKC potentiation on the extracellular Ca 2ϩ concentration was investigated over the range of 0.1-10 mM extracellular Ca 2ϩ ( Fig. 2) . At higher extracellular Ca 2ϩ concentrations (5-10 mM), the control currents of each of the NR1 splice variants (but not necessarily Ca 2ϩ flux through the channel) were reduced compared with those observed at 0.1 mM Ca 2ϩ (Fig. 2 A; also see Jahr and Stevens, 1993) . However, PKC potentiation was markedly increased for both receptors (Fig. 2) . Much of the increase in potentiation of NR1 011 was a result of decrease in control responses rather than increase in the potentiated re- Ringer's solution (bottom records). In C a 2ϩ Ringer's solution, splicing in the N1 cassette and splicing out the C1 and C2 cassettes increased the degree of PKC potentiation. In Ba 2ϩ Ringer's solution, splicing out the C1 and C2 cassettes increased PKC potentiation, but the N1 cassette had little or no effect. In Ba 2ϩ Ringer's solution, current amplitudes of all three splice variants lacked the initial peak current and late, slow rising phase observed in some records in C a 2ϩ Ringer's solution. Each pair of records (before and after TPA) is from a different oocyte. Arrowheads indicate levels at which currents were measured. Current calibration is 100 nA for NR1 011 Ringer's solution. Potentiation was measured as the ratio of the NMDA-induced current (minimum current amplitude after the initial peak response) after TPA application (I TPA ) to the control current before TPA application (I control ). In Ca sponses; however, if single-channel conductance was unaffected by potentiation, open probability must have been increased at elevated C a 2ϩ . PKC -induced potentiation of N R1 100 responses was decreased at 10 mM Ca 2ϩ , relative to that at 5 mM Ca 2ϩ ; the reduction may reflect greater C a 2ϩ -induced inactivation. These findings suggest that C a 2ϩ amplification of PKC potentiation increases with C a 2ϩ concentration over a considerable range. Because potentiation of N R1 011 is increased by increasing external C a 2ϩ , both N1 containing and N1 lacking splice variants may share a common mechanism of C a 2ϩ amplification.
Ca 2؉ amplification is not a result of Ca
Xenopus oocytes express endogenous chloride channels that are activated by cytoplasmic free C a 2ϩ [to generate I C l(C a) ]. We used the C l Ϫ channel blocker niflumic acid to test for possible contamination of the C a 2ϩ amplification of NMDA evoked responses by I C l(C a) . In Figure 3A niflumic acid at 0.5 mM, a concentration that largely blocks I C l(C a) evoked by Ca 2ϩ entry mediated by ionophore or through voltage-dependent Ca 2ϩ channels (Leonard and Kelso, 1990; White and Aylwin, 1990) , blocked 17% of the peak (measured to baseline) and 15% of the steadystate NMDA evoked currents in oocytes expressing NR1 100 / NR2A receptors at 1 mM external Ca 2ϩ and Ϫ60 mV holding potential (first pair of records). Niflumic acid acted rapidly, and we saw no difference between its action whether or not it was applied 20 sec before NMDA plus niflumic acid; the action was also rapidly reversible (see White and Aylwin, 1990) . After application of TPA, the same concentration of niflumic acid blocked 21% of the peak and 8% of the plateau phase of the potentiated NMDA responses (second pair of records). In another batch of oocytes, PKC potentiation was to 7.7 Ϯ 0.4-fold (n ϭ 3) and 8.2 Ϯ 0.5-fold (n ϭ 3) of control in the absence and presence of niflumic acid, respectively ( p Ͼ 0.05), indicating a negligible contribution of I C l(C a) to the measured PKC potentiation. The persistence of an initial peak in niflumic acid suggests that there is a contribution of receptor desensitization to this peak.
We also tested for a contribution of I C l(C a) by measuring PKC potentiation near the Cl Ϫ reversal potential, E C l . E C l is approximately Ϫ20 mV in the oocytes, as shown by reversal of a component of the early peak at this potential (Fig. 3B) . At Ϫ12 mV, the NMDA response has three phases, an inward current through the NMDA receptors, a somewhat delayed outward current ascribable to I C l(C a) , and a later plateau current that is again through the NMDA receptors. The data in Figure 3A indicate that the plateau phase has little I C l(C a) component. At Ϫ18 mV, the same components are seen, but the net current at the time of the peak in I C l(C a) is inward. At potentials of Ϫ20 mV or more negative, the initial NMDA and I C l(C a) peaks are not distinguishable in these records. The presence near E C l of an initial NMDA peak greater than the plateau indicates that desensitization contributes to the peak at more negative voltages, as is also indicated by the persistence of the peak in niflumic acid (Fig. 3A) . We compared the PKC potentiation observed at Ϫ20 and Ϫ60 mV of NMDA splice variants that do and do not show Ca 2ϩ amplification in 1 mM Ca 2ϩ
. In responses of oocytes expressing NR1 011 , which do not show Ca 2ϩ amplification, the degree of potentiation at Ϫ20 mV did not differ significantly from that at Ϫ60 mV (2.9 Ϯ 0.3 at Ϫ20 mV versus 3.1 Ϯ 0.7 at Ϫ60 mV), indicating that I C l(C a) does not contribute significantly to PKC potentiation of these receptors (Fig. 3C,D) . Responses of oocytes expressing NR1 111 and NR1 100 exhibited some reduction (35-45%) in PKC potentiation at Ϫ20 mV compared with Ϫ60 mV ( p Ͻ 0.05 for NR1 111 ; p Ͻ 0.01 for NR1 100 ), which is consistent with reduced Ca 2ϩ influx attributable to the reduced driving force at the more depolarized potential. PKC potentiation of NR1 111 receptors did remain greater than that of NR1 011 receptors ( p Ͻ 0.005), although potentiation of the two receptors was essentially the same in Ba 2ϩ (Fig. 1 B) . Because Ca 2ϩ amplification was not abolished at Ϫ20 mV, we conclude that it is not a result of Ca 2ϩ -activated Cl Ϫ current. Although splicing in the C1 and C2 cassettes reduced potentiation in Ba 2ϩ at Ϫ60 mV, this effect was not present at Ϫ20 mV.
Ca
2؉ amplification requires extracellular Ca 2؉ during opening of the NMDA channel, not during TPA application
To determine whether extracellular Ca 2ϩ acts during TPA application and/or in a subsequent step (e.g., opening of the NMDA channel), we substituted 1 mM Ba 2ϩ for 1 mM Ca 2ϩ during (1) TPA application; (2) both TPA and NMDA application; and (3) NMDA application only. For the oocytes illustrated in Figure 4 , A and B, application of TPA in Ba 2ϩ Ringer's solution potentiated the NMDA response measured in Ca 2ϩ Ringer's solution (Fig. 4 B) to a level similar to that observed when TPA was applied in Ca 2ϩ Ringer's solution (Fig. 4 A; to 7.7 and 8.3 times . In an oocyte expressing NR1 100 /NR2A receptors, niflumic acid (0.5 mM) reduced the peak of the NMDA response by 17% and the plateau by 15% before TPA application ( first pair of records, 300 M NMDA with 10 M glycine). After TPA application, niflumic acid reduced the peak by 21% and the plateau by 8% (second pair of records). Potentiation with and without niflumic acid was 8.2 Ϯ 0.5 (n ϭ 3) and 7.7 Ϯ 0.4 (n ϭ 3), respectively. Lower gain after 10 min TPA application. B, E Cl is near Ϫ20 mV. At Ϫ12 mV the NMDA response was triphasic, the first inward phase representing current through NMDA receptors, the second outward phase resulting from superposition of I C l(C a) , and the third again being primarily NMDA current. An initial NMDA peak clearly seen at Ϫ12 and Ϫ18 mV is not separable from I C l(C a) at more negative potentials. C, D, Ca 2ϩ amplification persists near E Cl . C, Sample records showing NMDA elicited responses before and after PKC potentiation at Ϫ20 and Ϫ60 mV of NR1 011 , NR1 111 , and NR1 100 receptors. The plateau phase of the responses was reduced at Ϫ20 mV; the initial peak was reduced to a greater extent. Current calibrations are in the order of the pairs of records. D, PKC potentiation from records like those in C. Potentiation of NR1 011 receptors was essentially the same at Ϫ20 and Ϫ60 mV, indicating that there was no contribution from I C l(C a) . For both NR1 111 and NR1 100 receptors, PKC potentiation measured at Ϫ20 mV was smaller than that measured at Ϫ60 mV ( p Ͻ 0.05 for NR1 111 ; p Ͻ 0.1 for NR1 100 receptors). The reduction in potentiation may have been a result of decrease in the driving force for Ca 2ϩ . At Ϫ20 mV potentiation of NR1 111 receptors was greater than that of NR1 011 receptors ( p Ͻ 0.005); potentiation of the two receptors was virtually identical in Ba 2ϩ (Fig. 1C ) . Thus, even at Ϫ20 mV, PKC potentiation of the NR1 111 receptor shows Ca 2ϩ amplification. control, respectively). In Figure 4 , C and D, application of TPA in Ba 2ϩ Ringer's solution potentiated the NMDA response measured in Ba 2ϩ (Fig. 4C ) to a level similar to that observed when TPA was applied in C a 2ϩ Ringer's solution (Fig. 4 D (Fig. 4 F) . Transfer of the oocyte from Ba 2ϩ to C a 2ϩ resulted in a rapid rise to the potentiation level observed in C a 2ϩ ; the response was characterized by a peak, followed by a decay to a plateau value. Transfer of the oocyte from C a 2ϩ to Ba 2ϩ resulted in a rapid return to near the potentiated level in Ba 2ϩ . These findings suggest that C a 2ϩ amplifies the NMDA response, and that onset and decay of the C a 2ϩ amplification are too rapid to be resolved within the limitations of perf usion in the oocyte system.
2؉ amplification requires a rise in intracellular free Ca
2؉
To test whether a rise in intracellular C a 2ϩ is required for Ca 2ϩ amplification of NMDA responses, we measured TPA potentiation with and without pretreatment of oocytes with the membrane-permeant C a 2ϩ chelator BAP TA-AM. In Figure 5A , PKC potentiation was to 12.5 times control in C a 2ϩ Ringer's solution and to 6.8 times control in Ba 2ϩ Ringer's solution. Pretreatment with BAP TA-AM for 20 min had little effect on steady-state currents in C a 2ϩ or in Ba 2ϩ (although it did reduce the initial peak in C a 2ϩ ), but after BAP TA, PKC potentiation of NR1 100 receptors measured in C a 2ϩ was reduced to 7.8 times control, a value near that obtained in Ba 2ϩ (6.4 times control; Fig.  5B ). To determine whether BAP TA-AM inhibits activation of PKC by TPA, BAP TA-AM was applied to another oocyte after treatment with TPA (Fig. 5C ). Under these conditions, PKC potentiation was similar in C a 2ϩ and in Ba 2ϩ , i.e., to 5.5 and 5.7 times control, respectively, and was close to that in Ba 2ϩ without BAP TA treatment (Fig. 5A) . In an additional batch of oocytes expressing N R1 100 , we compared potentiation in controls and after BAP TA treatment, as in Figure 5 , A and B. BAPTA treatment reduced potentiation measured in C a 2ϩ to a level not significantly different from that in Ba 2ϩ without BAPTA (Fig.  5D) . Thus, BAP TA treatment blocks C a 2ϩ amplification. BAP TA also reduced PKC potentiation measured in Ba 2ϩ compared with the control potentiation measured in Ba 2ϩ , but the effect was not significant ( p Ͼ 0.05). These findings indicate that this degree of BAP TA treatment reduces or blocks Ca 2ϩ amplification of the PKC -potentiated response but has little effect on PKC action or on the response measured in Ba 2ϩ . Longer BAP TA treatment reduced potentiation in Ba 2ϩ to a greater extent, which may reflect a requirement for cytoplasmic Ca 2ϩ in TPA action. Ringer's solution were little affected by BAP TA-AM application. Subsequent application of TPA (in C a 2ϩ Ringer's solution) potentiated the responses to 6.4-fold in Ba 2ϩ and 7.8-fold in C a 2ϩ ; i.e., BAPTA had little effect on PKC potentiation measured in Ba 2ϩ but reduced the potentiation measured in C a 2ϩ to near the level measured in Ba 2ϩ . C, A third oocyte was incubated in 0.25 mM BAP TA-AM for 20 min after 10 min in 100 nM TPA. PKC potentiation measured in C a 2ϩ Ringer's solution was reduced to 5. To characterize f urther the effect of C a 2ϩ on PKC-potentiated responses, we engineered the mutations N598R (for N1-lacking receptors) and N619R (for N1-containing receptors) in the M2 (channel lining or P) region of each of the three NR1 splice variants (Fig. 6 A) . Introduction of an Arg in place of N598 greatly reduces C a 2ϩ permeability of recombinant NMDA receptors Kawajiri and Dingledine, 1993; Sakurada et al., 1993 ). In C a 2ϩ Ringer's solution, current amplitudes in oocytes expressing the NMDA receptor channel mutant were reduced compared with those of wild-type receptors and lacked the initial peak (Fig. 6 B; currents were measured in oocytes from the same batch injected with the same amount of RNA). PKC potentiation of the mutant NR1 011 (N598R) receptors did not differ significantly from that of wild-type NR1 011 receptors (2.6 Ϯ 0.4-vs 3.1 Ϯ 0.2-fold in Ca 2ϩ Ringer's solution; Fig. 6C , wild-type data from Fig. 1 B) . However, PKC potentiation of NR1 111 (N619R) receptors was markedly reduced relative to that of the corresponding wild-type receptor (3.2 Ϯ 0.4-vs 6.2 Ϯ 0.4-fold). PKC potentiation of NR1 100 (N619R) receptors was also reduced relative to that of the corresponding wild-type receptor (5.1 Ϯ 0.5-vs 12.2 Ϯ 0.8-fold). In all three cases, PKC potentiation of the mutant NMDA receptor measured in Ca 2ϩ Ringer's solution was similar to that of the corresponding wild-type receptor measured in Ba 2ϩ Ringer's solution (Fig. 6C) . Thus, the M2 channel mutation abolished the Ca 2ϩ amplification.
PKC potentiation and Ca 2؉ amplification are independent of agonist concentration
To investigate further whether PKC potentiation and Ca 2ϩ amplification are reduced under conditions of reduced Ca 2ϩ influx, we compared PKC potentiation of NR1 011 and NR1 100 receptors at 5 and 300 M NMDA (with 10 M glycine). For NR1 011 receptors, the current amplitude at 5 M NMDA was 55 Ϯ 8% of that at 300 M NMDA; for NR1 100 receptors, the current amplitude at 5 M NMDA was 19 Ϯ 4% of that at 300 M NMDA. The degree of PKC potentiation, however, was similar at the two agonist concentrations (4.4 Ϯ 0.4 at 5 M NMDA vs 3.7 Ϯ 0.3 at 300 M NMDA for NR1 011 receptors; 9.8 Ϯ 1.9 at 5 M NMDA vs 8.7 Ϯ 0.4 at 300 M NMDA for NR1 100 receptors) (Fig. 7) . The finding that PKC potentiation is unchanged at low agonist concentration suggests that Ca 2ϩ amplification is the same at low and high mean current levels per channel. It follows that Ca 2ϩ amplification requires neither spatial summation of Ca 2ϩ influx from neighboring channels nor temporal summation of Ca 2ϩ influx from successive periods when the receptor is f ully occupied by agonists during NMDA and glycine application. (Temporal summation might occur between successive openings in a burst.) Ca 2ϩ inactivation of NMDA receptors also occurs at low agonist concentration (Legendre et al., 1993) and thus also appears not to require summation of C a 2ϩ influx from successive binding events or neighboring channels.
Neutralization of positively charged residues within the N1 splice cassette reduces PKC potentiation of NMDA receptors
The N1 splice cassette alters agonist affinity, current amplitude, spermine and Z n 2ϩ potentiation, and proton inhibition of recombinant NMDA receptors (Durand et al., 1992 (Durand et al., , 1993 Hollmann et al., 1993; Traynelis et al., 1995) , and many of these effects are reversed by neutralization of positive charges in N1. To determine whether the greater PKC potentiation observed for splice variants containing the N1 cassette is affected by the presence of the six positively charged residues, we substituted the neutral amino acid alanine for each of three positively charged residues at either end of the N1 splice cassette (N1-1 and N1-2) or for all six positively charged residues (N1-3; Fig. 8 A) . The three mutant receptors exhibited reduced current amplitudes relative to that of the wild-type NR1 111 receptor (data not illustrated). In C a 2ϩ Ringer's solution, PKC potentiation of N1-1, N1-2, and N1-3 receptors was reduced markedly relative to that of wild-type N R1 111 receptors (to 3.5 Ϯ 0.4-, 2.9 Ϯ 0.3-, and 4.1 Ϯ 0.5-fold of control responses, respectively) and was similar to potentiation of wild-type NR1 011 receptors (3.1 Ϯ 0.2-fold; Fig. 8 B) . Because neutralization of the positive charges in the N1 insert reduces current amplitude (defined as the NMDA response obtained after injection of a constant amount of RNA) (Hollmann et al., 1993; Zheng et al., 1994) , reduction in C a 2ϩ influx could account for the observed decrease in PKC potentiation. Ringer's solution than when measured in Ba 2ϩ Ringer's solution. The data are consistent with a mechanism in which Ca 2ϩ entering through the activated receptor binds to the channel or a closely associated molecule to increase channel opening; this amplification would be greater after PKC action. Contamination by C a 2ϩ -activated C l Ϫ currents was minimal as discussed below. Ca 2ϩ was effective when present during the application of NMDA and had no effect during activation of PKC by TPA. The evidence that the amplification requires a rise in intracellular Ca 2ϩ is the following: (1) amplification is increased by increasing extracellular C a 2ϩ (Fig. 2) ; (2) amplification is reduced by depolarizing to reduce the driving force for C a 2ϩ (Fig. 3) ; (3) amplification is reduced in mutant receptors with reduced Ca 2ϩ permeability (Fig. 6) ; and (4) amplification is prevented by applying a membrane-permeant form of the C a 2ϩ chelator BAPTA (Fig.  5) . In addition, the splice variants containing the N1 cassette exhibit greater C a 2ϩ amplification (Fig. 1) , possibly because they generate larger currents, which could be associated with greater Ca 2ϩ influx. The reduced amplification observed after neutralization of positive charges in the N1 cassette (Fig. 8) is consistent with this interpretation, because these mutations reduce current amplitude. Furthermore, the N1-lacking receptor, NR1 011 , which has a smaller current amplitude, exhibited Ca 2ϩ amplification at increased extracellular Ca 2ϩ ; thus, the N1 cassette is not required for Ca 2ϩ amplification. The degree of Ca 2ϩ amplification was evaluated by comparison with responses in Ba 2ϩ . Ba 2ϩ is unlikely to have any amplifying effect, because potentiation in Ba 2ϩ was similar to that in Ca 2ϩ after BAPTA (Fig. 5 ) and to that of the mutant receptor with reduced Ca 2ϩ permeability (Fig. 6) PKC, it is unlikely that PKC increases channel conductance. Another possibility might be that PKC increases the plateau response by reducing C a 2ϩ -dependent inactivation. This mechanism is unlikely, because the action of BAP TA indicates that there is little C a 2ϩ -dependent inactivation either before or after TPA application. (Moreover, the inactivation would have to be rapid enough to be undetected in the rising phase of the response to bath applied agonists.) A final possibility to be considered is that C a 2ϩ causes insertion of new receptor molecules. This mechanism also appears unlikely because of the rapid onset and reversibility of the C a 2ϩ amplification (Fig. 4) .
DISCUSSION
Ca
2؉ amplification is not an artifact of Ca 2؉ -activated chloride current
A number of observations indicate that I C l(C a) does not contribute significantly to PKC potentiation or C a 2ϩ amplification, as measured in this study. (1) The chloride channel blocker, niflumic acid, had only a small effect on the amplitude of the plateau responses and did not reduce PKC potentiation measured in 1 mM Ca 2ϩ Ringer's solution at Ϫ60 mV (Fig. 3A) . Leonard and Kelso (1990) reported a greater effect of niflumic acid on NMDA responses in oocytes expressing rat brain mRNA, but this difference may have resulted from use of brain mRNA, which may encode additional C a 2ϩ -activated C l Ϫ channels and from recording at Ϫ80 mV in 2 mM external C a 2ϩ , which would increase I C l(C a) . (2) C a 2ϩ amplification is present at Ϫ20 mV, a value near E C l in oocytes (Fig. 3B,C) . At this holding potential, the chloride current is small, but C a 2ϩ amplification persists, although reduced, presumably because of the reduced driving force for Ca 2ϩ influx. (3) We measure in oocytes a reversal potential for recombinant NMDA receptors of about Ϫ5 mV (data not illustrated; also see Hollmann et al., 1993) . This value is close to that reported for neuronal NMDA receptors (cf. Mayer and Westbrook, 1987) , which indicates that there is little I C l(C a) contribution. (4) The degree of C a 2ϩ amplification was not changed when Ca 2ϩ influx was reduced by reducing agonist concentration (Fig.  7) . Also, the degree of C a 2ϩ amplification was the same for oocytes generating large and small currents in response to saturating NMDA, reflecting differences in the level of receptor expression (data not illustrated). I (C a)C l would be expected to decrease with decrease in NMDA elicited currents.
Are Ca
2؉ influx and Ca 2؉ amplification during NMDA application regenerative?
The mechanism of the proposed C a 2ϩ amplification is as yet unknown, but single-channel studies and mutational analysis will undoubtedly f urther elucidate the molecular basis. C a 2ϩ may act directly on the channel protein or on a closely associated accessory protein expressed by the Xenopus oocyte. C andidate proteins are calmodulin and C a 2ϩ -and calmodulindependent kinases, implicated in NMDA-dependent LTP. The rapid rise in current amplitude on transfer of the oocyte from Ba 2ϩ to C a 2ϩ Ringer's solution and rapid decay on transfer from C a 2ϩ to Ba 2ϩ Ringer's solution argues against a covalent modification, such as phosphorylation or dephosphorylation and in favor of a direct action of C a 2ϩ (or C a 2ϩ -calmodulin complex) on the cytoplasmic face of the receptor. C a 2ϩ -calmodulin binds to a site in the C1 cassette and a site in C0, the region between TM4 and C1 of the N R1 subunit. However, binding to these sites decreases channel open time in heteromeric receptors with N R2A expressed in H EK 293 cells (Ehlers et al., 1996) .
The Ca 2ϩ amplification should tend to be regenerative. However, in our experiments the amplification was independent of agonist concentration (Fig. 7) . This finding, together with our observation that Ca 2ϩ amplification is independent of the level of receptor expression (data not shown), suggests that there was neither spatial summation of Ca 2ϩ influx from neighboring channels nor temporal summation of Ca 2ϩ influx from successive bursts of openings caused by periods of full occupancy of the receptor by NMDA and glycine. It follows that under these conditions there was no regenerative response.
As noted above, neuronal receptors can show Ca 2ϩ -dependent inactivation (Legendre et al., 1993; Rosenmund et al., 1995) . In recombinant receptors expressed in HEK 293 cells, Ca 2ϩ -dependent inactivation is affected by the NR2 subunit, being greatest in NR1/NR2A receptors, less in NR1/NR2B receptors, and virtually absent in NR1/NR2C receptors (Krupp et al., 1996) . In Xenopus oocytes, increase in extracellular Ca 2ϩ was reported to increase NMDA response amplitude comparable to the Ca 2ϩ amplification proposed here; however, unlike the results in Figure 2 , the response amplitude was not reduced at higher concentrations of Ca 2ϩ (Koltchine et al., 1996) . Recombinant NMDA receptors expressed in Xenopus oocytes exhibit a late, slowly rising phase in NMDA responses, particularly evident in N1-containing NR1 receptors, in the presence or absence of activators of PKC (Figs. 1 A, 5) (Koltchine et al., 1996) . This slow, Ca 2ϩ -dependent response is more likely to occur at higher agonist concentrations and after PKC potentiation. It may represent the release of Ca 2ϩ from intracellular pools, although the persistence of the response in BAPTA argues against this mechanism.
Does PKC potentiation involve phosphorylation of the NR1 protein?
PKC phosphorylates specific serine residues in the NR1 011 receptor expressed transiently in HEK 293 cells (Tingley et al., 1993) . The four identified series are contained in the C1 cassette, although our electrophysiological findings indicate that splicing out the C1 and C2 cassettes increases PKC potentiation ( Fig. 1 ) (Durand et al., 1992 (Durand et al., , 1993 . Thus, PKC potentiation may not require phosphorylation of the receptor itself, and phosphorylation of C1 may even reduce PKC potentiation. In agreement, mutation of the phosphorylatable serines to alanines increases TPA potentiation (Zhang et al., 1996) . It is then reasonable to suggest that there is another molecule associated with NR1, phosphorylation of which is responsible for the potentiation. An obvious possibility is NR2A and/or B, which apparently are phosphorylated by PKC (Hall and Soderling, 1997; Leonard and Hell, 1997) Functional significance of the Ca 2؉ amplification
Although our experiments were performed on recombinant NMDA receptors expressed in Xenopus oocytes, C a 2ϩ amplification is likely to occur after PKC potentiation of neuronal NMDA receptors. As noted above, PKC potentiates NMDA receptors in neurons from hippocampus (Aniksztejn et al., 1992) , trigeminal nucleus (Chen and Huang, 1992) , and spinal cord (Gerber et al., 1989) . In our study, extracellular C a 2ϩ and alternative splicing were shown to affect PKC potentiation. These results together with the finding that expression of N R1 splice variants is temporally and spatially regulated (Laurie and Seeburg, 1994; Zukin and Bennett, 1995; Paupard et al., 1997 ) provide a mechanism whereby NMDA signals can be amplified in specific neuronal populations at times of enhanced synaptic activity. Thus, PKC potentiation of NMDA responses may have a significant impact on cellular events including induction of long-term potentiation and synaptogenesis. C a 2ϩ amplification, if present in neurons, may have particularly important actions in small structures such as dendritic spines, where influxes through neighboring receptor channels would be more likely to interact.
